Translational approaches to addressing complex genetic pathways in colorectal cancer

Translational Research

Volumn 151, Issue 1, 2008, Pages 10-16

  Early, Dayna S ^a   Fontana, Luigi ^a,b   Davidson, Nicholas O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; ACETYLSALICYLIC ACID; APC PROTEIN; BETA CATENIN; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CYCLOOXYGENASE 2; ESTRADIOL; ESTROGEN; GESTAGEN; PLACEBO; PROSTAGLANDIN SYNTHASE; WNT PROTEIN;

ADENOMATOUS POLYP; ALLELE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; DOMINANT GENE; ENVIRONMENTAL FACTOR; ESTROGEN THERAPY; GENE INTERACTION; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HORMONE SUBSTITUTION; HUMAN; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; NONHUMAN; OBESITY; PATHOGENESIS; PENETRANCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 36448939776     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.09.002     Document Type: Review

References (60)

1. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
2. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 4 (2004) 769-780
3. Sjoblom T., Jones S., Wood L.D., et al. The consensus coding sequences of human breast and colorectal cancers. Science 314 (2006) 268-274
4. Chan A.T., Ogino S., and Fuchs C.S. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356 (2007) 2131-2142
5. Sandler R.S., Halabi S., Baron J.A., et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348 (2003) 883-890
6. Turini M.E., and DuBois R.N. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 53 (2002) 35-57
7. Castellone M.D., Teramoto H., Williams B.O., Druey K.M., and Gutkind J.S. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 310 (2005) 1504-1510
8. Sonoshita M., Takaku K., Sasaki N., et al. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat Med 97 (2001) 1048-1051
9. Mutoh M., Watanabe K., Kitamura T., et al. Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res 62 (2002) 28-32
10. Oshima M., Dinchuk J.E., Kargman S.L., et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87 (1996) 803-809
11. Sheng H., Shao J., Kirkland S.C., et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99 (1997) 2254-2259
12. Writing group for the Women's Health Initiative Investigators. Risks and benefits of hormone replacement therapy in healthy postmenapausal women. JAMA 288 (2002) 321-333
13. Chlebowski R.T., Wactawski-Wende J., Ritenbaugh C., et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 350 (2004) 991-1004
14. Anderson G.L., Limacher M., Assaf A.R., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. [see comment]. JAMA 291 (2004) 1701-1712
15. Mukhopadhyay T., and Roth J.A. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene 14 (1997) 379-384
16. Schumacher G., Kataoka M., Roth J.A., and Mukhopadhyay T. Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin Cancer Res 5 (1999) 493-499
17. Carothers A.M., Hughes S.A., Ortega D., and Bertagnolli M.M. 2-Methoxyestradiol induces p53-associated apoptosis of colorectal cancer cells. Cancer Lett 187 (2002) 77-86
18. Konstantinopoulos P.A., Kominea A., Vandoros G., et al. Oestrogen receptor beta (ERbeta) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur J Cancer 39 (2003) 1251-1258
19. Hsu H.H., Cheng S.F., Chen L.M., et al. Over-expressed estrogen receptor-alpha up-regulates hTNF-alpha gene expression and down-regulates beta-catenin signaling activity to induce the apoptosis and inhibit proliferation of LoVo colon cancer cells. Mol Cell Biochem 289 (2006) 101-109
20. Qiu Y., Langman M.J., and Eggo M.C. Targets of 17beta-oestradiol-induced apoptosis in colon cancer cells: a mechanism for the protective effects of hormone replacement therapy?. J Endocrinol 181 (2004) 327-337
21. Takahashi Y., Kitadai Y., Bucana C.D., Cleary K.R., and Ellis L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55 (1995) 3964-3968
22. Stammermann G.N., Nomura A.M., Chyou P.H., Kato I., and Kuroishi T. Cancer incidence in Hawaiian Japanese: migrants from Okinawa compared with those from other prefectures. Jpn J Cancer Res 82 (1991) 1366-1370
23. Minami Y., Nishino Y., Tsubono Y., Tsuji I., and Hisamichi S. Increase of colon and rectal cancer incidence rates in Japan: trends in incidence rates in Miyagi Prefecture. J Epidemiol 16 (2006) 240-248
24. Lichtenstein P., Holm N.V., Verkasalo P.K., et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark and Finland. N Engl J Med 343 (2000) 78-85
25. Calle E.E., and Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4 (2004) 579-591
26. Giovannucci E., Ascherio A., Rimm E.B., Colditz G.A., Stampfer M.J., and Willett W.C. Physical activity, obesity, and risk of colon cancer and adenoma in men. Ann Intern Med 122 (1995) 327-334
27. Giovannucci E., Colditz G.A., Stampfer M.J., and Willett W.C. Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 7 (1996) 253-263
28. Russo A., Franceschi S., La Vecchia C., et al. Body size and colorectal cancer risk. Int J Cancer 78 (1998) 161-165
29. Otake S., Takeda H., Suzuki Y., et al. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 22 (2005) 3642-3646
30. Newmark H.L., Lipkin M., and Maheshwari N. Colonic hyperplasia and hyperproliferation induced by a nutritional stress diet with four components of Western-style diet. J Natl Cancer Inst 82 (1990) 491-496
31. Newmark H.L., Yang K., Lipkin M., et al. A Western-style diet induces benign and malignant neoplasms in the colon of normal C57BL/6 mice. Carcinogenesis 22 (2001) 1871-1875
32. Yakar S., Nunez N.P., Pennisi P., et al. Increased tumor growth in mice with diet-induced obesity: impact of ovarian hormones. Endocrinology 147 (2006) 5826-5834
33. Hursting S.D., Lavigne J.A., Berrigan D., Perkins S.N., and Barrett J.C. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 54 (2003) 131-152
34. Giovanella B.C., Shepard R.C., Stehlin J.S., Venditti J.M., and Abbott B.J. Calorie restriction: effect on growth of human tumors heterotransplanted in nude mice. J Natl Cancer Inst 68 (1982) 249-257
35. Reddy B.S., Wang C.X., and Maruyama H. Effect of restricted caloric intake on azoxymethane-induced color tumor incidence in male F344 rats. Cancer Res 47 (1987) 1226-1228
36. Lasko C.M., Good C.K., Adam J., and Bird R.P. Energy restriction modulates the development of advanced preneoplastic lesions depending on the level of fat in the diet. Nutr Cancer 33 (1999) 69-75
37. Fontana L., and Klein S. Aging, adiposity, and calorie restriction. JAMA 297 (2007) 986-994
38. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
39. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004) 2548-2556
40. Fontana L., Eagon J.C., Trujillo M.E., Scherer P.E., and Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56 (2007) 1010-1013
41. Dunn S.E., Kari F.W., French J., et al. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57 (1997) 4667-4672
42. Matsuzaki J., Kuwamura M., Yamaji R., Inui H., and Nakano Y. Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice. J Nutr 131 (2001) 2139-2144
43. Koenuma M., Yamori T., and Tsuruo T. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma. Jpn J Cancer Res 80 (1989) 51-58
44. Koohestani N., Tran T., Lee W., Wolever T.M., and Bruch W.R. Insulin resistance and promotion of aberrant crypt foci in the colons or rats on a high-fat diet. Nutrit Cancer 29 (1997) 69-76
45. Tran T., Medline A., and Bruce W. Insulin promotion of colon tumors in rats. Cancer, Epidemiol, Biomarkers Prev 5 (1996) 1013-1015
46. Giovannucci E. Insulin, insulin-like growth factors and colon cancer. J Nutr 131 (2001) 3109S-3120S
47. Giovannucci E. Insulin-like growth factor-I and binding protein-3 and risk of cancer. Hormone Res 51 (1999) 34-41
48. LeRoith D., Baserga R., Helman L., and Roberts Jr. C.T. Insulin-like growth factors and cancer. Ann Intern Med 122 (1995) 54-59
49. Edinger A.L. Growth factors regulate cell survival by controlling nutrient transporter expression. Biochem Soc Trans 33 (2005) 225-227
50. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens bad neighbors. Cell 120 (2005) 513-522
51. Keaney J.F.J., Larson M.G., Vasan R.S., et al. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23 (2003) 434-439
52. Valko M., Izakovic M., Mazur M., Rhodes C.J., and Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266 (2004) 37-56
53. Liu Z., Uesaka T., Watanabe H., and Kato N. High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int J Oncol 19 (2001) 1009-1014
54. Attoub S., Noe V., Pirola L., et al. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J 14 (2000) 2329-2338
55. Hardwick J.C., Van Den Brink G.R., Offerhaus G.J., Van Deventer S.J., and Peppelenbosch M.P. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 121 (2001) 79-90
56. Hoda M.R., Keely S.J., Bertelsen L.S., Junger W.G., Dharmasena D., and Barrett K.E. Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg 94 (2007) 346-354
57. Kaaks R., Toniolo P., Akhmedkhanov A., et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Nat Cancer Inst 92 (2000) 1592-1600
58. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 6 (1995) 164-179
59. Murphy T., Calle E., Rodriguez C., Khan H., and Thun M. Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol 152 (2000) 847-854
60. Caan B., Coates A., Slattery M.L., Potter J.D., Quesenberry C., and Edwards S. Body size and colon cancer in a large case-control study. Internat J Obesity Relat Metab Disord 22 (1998) 178-184